| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.48 | 0.006 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.006 |